| Authors: |
El-Khoueiry AB; Division of Medical Oncology/Hematology, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA., Kim RD; Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA., Harris WP; Department of Medicine, University of Washington/Fred Hutchinson Cancer Center (FHCC), Seattle, Washington, USA., Sung MW; Division of Hematology and Oncology, Tisch Cancer Institute at Mount Sinai, New York, New York, USA., Waldschmidt D; Department of Gastroenterology and Hepatology, University Hospital Cologne, Cologne, Germany., Cabrera R; Division of Gastroenterology, Hepatology, and Nutrition, University of Florida, Gainesville, Florida, USA., Garosi VL; Bayer S.p.A., Milan, Italy., Ploeger BA; Bayer AG, Berlin, Germany., Zebger-Gong H; Bayer AG, Berlin, Germany., Brennan BJ; Bayer HealthCare Pharmaceuticals, Whippany, New Jersey, USA., Wang YA; Bayer HealthCare Pharmaceuticals, Cambridge, Massachusetts, USA., Mueller U; ClinStat GmbH, Huerth, Germany., Weispfenning A; Bayer AG, Berlin, Germany., Seidel H; Bayer AG, Berlin, Germany., Coppieters S; Bayer AG, Diegem, Belgium., Ishida TC; Bayer HealthCare Pharmaceuticals, Whippany, New Jersey, USA., Galle PR; Department of Internal Medicine, Mainz University Medical Center, Mainz, Germany. |
